Background: Robotic surgery is an alternative to minimally invasive surgery. The aim of this study was to report on current trends in robotic thoracic and cardiovascular surgical techniques in Korea. Methods: Data from the National Evidence-based Healthcare Collaborating Agency (NECA) between January 2006 and June 2012 were used in this study, including a total of 932 cases of robotic surgeries reported to NECA. The annual trends in the case volume, indications for robotic surgery, and distribution by hospitals and surgeons were analyzed in this study. Results: Of the 932 cases, 591 (63%) were thoracic operations and 340 (37%) were cardiac operations. The case number increased explosively in 2007 and 2008. However, the rate of increase regained a steady state after 2011. The main indications for robotic thoracic surgery were pulmonary disease (n=271, 46%), esophageal disease (n=199, 34%), and mediastinal disease (n=117, 20%). The main indications for robotic cardiac surgery were valvular heart disease (n=228, 67%), atrial septal defect (n=79, 23%), and cardiac myxoma (n=27, 8%). Robotic thoracic and cardiovascular surgeries were performed in 19 hospitals. Three large volume hospitals performed 94% of the case volume of robotic cardiac surgery and 74% of robotic thoracic surgery. Centralization of robotic operation was significantly (p＜0.0001) more common in cardiac surgery than in thoracic surgery. A total of 39 surgeons performed robotic surgeries. However, only 27% of cardiac surgeons and 23% of thoracic surgeons performed more than 10 cases of robotic surgery. Conclusion: Trend analysis of robotic and cardiovascular operations demonstrated a gradual increase in the surgical volume in Korea. Meanwhile, centralization of surgical cases toward specific surgeons in specific hospitals was observed.
Fig. 1. Annual trend of robotic thoracic and cardiovascular surgery.
In the early period, explosive increase of robotic surgery was observed. The rate of increase reached to steady state after 2010.
The recent development of robotic surgical technology has made robotic surgery another minimally invasive surgical option. A high-quality video system, three-dimensional view, free articulation of the robotic arms, motion scaling, and tremor filtering are specific features of the da Vinci robot system (Intuitive Surgical Inc., Sunnyvale, CA, USA) that can enhance the feasibility and improve the overall outcomes of minimally invasive surgery. Clinical studies on robotic surgery published in Korea have demonstrated that robotic surgery is more feasible and reliable than open thoracic or cardiovascular surgery [5] [6] [7] . However, it remains unclear how many robotic operations have been performed. The main indications for robotic surgery in Korea have not been established, and it is not known whether robots are being increasingly utilized in surgery in Korea. Therefore, the aim of this study was to identify overall trends in the occurrence of robotic thoracic and cardiovascular surgery in Korea by analyzing national data on robotic surgery collected by the National Evidence-Based Healthcare Collaborating Agency (NECA). (Table 1) .
METHODS

1) Data collection
2) Robotic thoracic surgery
The indications for robotic thoracic surgery are summarized in Table 2 . Three main indications were found for thoracic robotic surgery: pulmonary disease (n=271, 46%), esophageal disease (n=199, 34%), and mediastinal disease (n=117, 20%).
Lung cancer, esophageal cancer, and mediastinal tumors were the most common indications for thoracic robotic surgery (Table 2) . Only a very small number of robotic operations were performed for diseases of the chest wall, pleura, dia- 
3) Robotic cardiac surgery
The indications for cardiac surgery are summarized in Table 3 . Three major indications were found for robotic cardiac surgery: valvular heart disease (n=228, 67%), atrial septal defects (n=79, 23%), and cardiac myxoma (n=27, 8%). Mitral valve surgery was the most common general indication in the category of valvular heart disease, and the most common specific indication was mitral regurgitation without atrial fibrillation (n=167, 49%). Robotic operations for ischemic heart disease were only performed in eight patients (2%). The case volume of robotic cardiac operations has remained steady since 2008.
4) Per-hospital analysis
The case volumes of robotic surgery in each hospital are shown in Fig 
5) Per-surgeon analysis
One hospital did not submit data about the surgeons who performed robotic operations. Therefore, data about the surgeons were analyzed for 18 hospitals. A total of 39 surgeons performed robotic operations, including 26 thoracic surgeons and 13 cardiac surgeons. Seven surgeons (27%) performed more than 10 robotic thoracic operations, whereas three surgeons (23%) performed more than 10 robotic cardiac operations. Eleven hospitals (61%) had more than two surgeons who performed robotic surgery. Seven hospitals (39%) had only one surgeon who performed robotic surgery.
DISCUSSION
This is the first study to report annual trends in robotic thoracic and cardiovascular surgery in Korea. The analysis was performed using the NEHA database of information submitted by hospitals. Of a total of 932 cases, 63% were robotic thoracic surgery and 37% were robotic cardiac surgery.
The annual volume of robotic surgery has continuously increased. However, the rate of increase is now lower than it was immediately after being introduced. We evaluated the centralization of cases, and found that robotic cardiac surgery was significantly more centralized than robotic thoracic surgery.
Robotic surgery has technological advantages over conven- In this study, the most common indication for robotic thoracic surgery was lung cancer. Robot-assisted pulmonary resection was the major indication in other studies [8] .
Whether robotic pulmonary resection is superior to other sur- [11, 12] have reported comparable outcomes for robotic esophagectomy. A study conducted by Suda et al. [11] found that robotic surgery prevented vocal cord paralysis more effectively than thoracoscopic esophagectomy.
Mediastinal disease was another indication for robotic thoracic surgery. The superiority of robot-assisted surgery in the treatment of anterior mediastinal tumors has been established in several studies [7, 13, 14] . A shorter length of stay, less blood loss, and fewer complications than open sternotomy have been reported [7, 13] Robotic thymectomy was also found to have better results regarding control of myasthenia gravis than thoracoscopic thymectomy [14] . In anterior mediastinal disease, better outcomes after robotic surgery have been repeatedly reported. However, no large series has yet been reported.
In this study, the most common indication for robotic cardiac surgery was valvular heart disease. Mitral valve repair has been established as the major indication for robot-assisted cardiac surgery in other studies [4] . However, it is not clear whether robotic mitral valve repair is superior to other surgical modalities. Robotic surgery is likely to share the advan- directly be applied to the Korean medical system due to fundamental differences in medical costs and the insurance system. Woo and Nacke [16] reported that robotic surgery patients had a significant reduction in blood transfusions and length of stay compared to sternotomy patients. Folliguet et al. [17] reported that the only advantage of robotic surgery was a shorter hospital stay (7 days vs. 9 days, p=0.05).
Repair for atrial septal defects was the second most common indication for robotic cardiac surgery. Kim et al. [6] reported that robotic atrial septal defect closure was a feasible operation with acceptable early outcomes. No instances of mortality or serious surgical complications were observed in the 50 patients included in their study. They concluded that, in selected patients, complete port access can be helpful for obtaining better cosmetic results with less musculoskeletal injury. No study has been carried out comparing robotic and thoracoscopic atrial septal defect closure.
Cardiac myxoma was another indication for robotic surgery.
Gao et al. [18] reported that excellent results were obtained Robot-assisted coronary artery bypass is a possible option for certain patients. Although some surgeons have reported some degree of experience with total endoscopic coronary bypass (TECAB), the complexity and the lack of long-term results after the procedure made it difficult to perform TECAB routinely [19, 20] .
In this study, we found that the case volume of robot-assisted surgery in Korea has increased over the study period.
Although it is difficult to compare Korean data to data from other countries, analogous findings have been reported in other countries. Kent et al. [8] reported that the case volume of robot-assisted lung surgery in the United States increased from 0.2% to 3.4% between 2008 and 2010, while the case volume of thoracotomy decreased from 66% to 57%, representing a gradual increase in robotic surgery for major lung disease.
However, the rate of increase in the case volume showed the characteristic pattern of change for new surgical procedures, which involves early growth and a later slowdown.
Although the reason for this phenomenon is unclear, one of the causes may be the small number of surgeons who performed robotic surgery. During the study period, the number of surgeons who performed robotic surgery did not increase significantly. There may be many reasons why many surgeons are reluctant to perform robotic surgery, such as lack of evidence, higher cost, and resistance to new technology.
However, in this study, we were not able to determine which of the above considerations was the most important.
In this study, the annual case volume of robotic thoracic and cardiovascular surgery was found to have increased gradually. However, centralization in several centers was also observed. Centralization is an issue in the improvement of surgical outcomes. Hanneman et al. [21] reported that reductions in six-month and two-year postoperative mortality were associated with increased surgical volumes of esophagectomy.
They found that the centralization of surgical esophagectomy was effectively established in the Netherlands. Centralization of robotic surgery has been documented for other diseases as well. Stitzenberg et al. [22] reported that both serial increases and decreases in prostatectomy volume were associated with robotic surgery. The volume increased in hospitals that obtained robots, but decreased in hospitals that never obtained a robot. This trend potentiates the centralization of surgical volume in high-volume centers, which results in an increased travel distance from the patient's home to the hospital. Anderson et al. [23] confirmed that the presence of a robot was associated with a higher prostatectomy volume. Whether the centralization is a result of active quality improvement interventions or patients' preferences for high-quality medical services is beyond the scope of this study. We believe that cen-
